INTRODUCTION
Psychoneuroimmunology is an interdisciplinary field concerned with the study of behavior-neuroendocrine-immune interactions and their potential health consequences (2) . This review focuses on the effects of stressors, and neuroendocrine responses to stressors, on the pathogenesis of, and immune response to, infectious disease.
Stress and Immunomodulation
In general, a stressor can be defined as any external or internal challenge that disrupts the internal environment. The mammalian response to a stressor involves a variety of adaptive physiologic mechanisms designed to restore homeostasis (131) . Physiologic responses to stressors are mediated primarily by two neuroendocrine systems: the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis. Elevations of tissue and plasma catecholamines result from increased SNS activity induced by a variety of stressors Treatment of animals with 6-hydroxydopamine, a toxin that destroys noradrenergic neurons, has been found to reduce the primary antibody response to T-dependent antigens (73, 108) and to suppress alloantigen-induced cytotoxic T-lymphocyte (CTL) activity (109) . In addition, it has been demonstrated that both primary and secondary lymphoid organs are directly innervated by noradrenergic postganglionic sympathetic neurons (44) . The distribution of nerve fibers in these organs suggests that immune effector cells contained within them are direct targets of this innervation (45 (614) 292-7619. activity comes from the demonstration of adrenergic receptors on immune cells. P-Adrenergic receptors are expressed on T and B lymphocytes, macrophages, neutrophils, and natural killer (NK) cells (1, 53, 55, 105, 110, 122) . Cells possessing these receptors would be expected to respond (depending on their state of activation) to neuronal norepinephrine and adrenal medullary epinephrine released during the SNS response to a stressor. The ability of mononuclear cells to respond to ,B-adrenergic receptor stimulation by elevating intracellular cyclic AMP has been suggested to be the primary mechanism by which catecholamines regulate immune responses (111) . In vitro and in vivo studies have shown that catecholamines alter a variety of immune responses. Modulatory effects of catecholamines on lymphocyte migration and proliferation, antibody secretion, cytotoxic activity, and macrophage activation have been demonstrated (102, 120, 151) . In addition, norepinephrine has been shown to inhibit cytokineinduced, major histocompatibility complex (MHC) class II antigen expression on antigen-presenting cells (52) .
Stressful stimuli also activate the HPA axis, leading, ultimately, to increases in plasma glucocorticoids (GC). Under conditions of stress, GC mediate adaptive metabolic, cardiovascular, and anti-inflammatory effects. GC actions are initiated through intracellular GC receptors. The production and secretion of GC by cells of the zona fasciculata of the adrenal cortex is stimulated by pituitary adrenocorticotropic hormone (ACTH) (5) . Stress-induced ACTH production is elicited primarily by hypothalamic corticotropin-releasing factor (CRF) (135, 155) . In addition to ACTH, CRF also stimulates the secretion of other peptides derived from expression of the proopiomelanocortin gene (41, 112) , including the opioid peptides ,B-endorphin and methionine-enkephalin. Although their precise roles in stress-induced physiologic responses are not yet fully understood, the opioid peptides have been implicated in learning and pain control responses (103) .
The ability of GC hormones to modulate immune responses has been widely studied (123) . Mononuclear cells possess receptors for GC (32, 160) , and direct suppressive effects of GC on immune effector cells have been demonstrated. GC inhibit interleukin 2 (IL-2) gene expression by lymphocytes at the transcriptional level and IL-1 gene expression by macrophages at both transcriptional and posttranscriptional levels (94, 106, 107, 124, 154) . In addition, they have been shown to inhibit MHC class II antigen expression, tumor necrosis factor production by macrophages (10, 148, 164) , and gamma interferon (IFN-y) synthesis. Intercellular adhesion molecule-I and IL-2 receptor expression are also inhibited by GC (64, 139) . GC also exert potent anti-inflammatory effects by inhibiting phospholipase A2 activity (11) and have been shown to alter lymphocyte trafficking (25, 43) . Furthermore, GC have been shown to inhibit T-cell binding to endothelial cells by modulating expression of adhesion molecules on these cells (40) . Recently, the immunomodulatory capabilities of other products of the HPA axis have been recognized. Functional receptors for CRF have been demonstrated on macrophages (158, 159) . CRF has also been shown to alter NK cell activity (20, 83, 84) , but this effect is thought to be centrally mediated and not due to a direct effect of CRF on NK cells (82) .
There is evidence, however, for direct effects of ACTH on several different types of immune cells, and ACTH receptors have been demonstrated on mononuclear cells (15, 88, 147) . ACTH has been shown to inhibit antibody production (89) and to enhance proliferation by B lymphocytes (17) . ACTH has also been shown to inhibit T-lymphocyte IFN-y production (90) and IFN-y-induced macrophage activation (102) and MHC class II expression (164) .
The potential immunomodulatory effects of the opioid peptides have also been recently recognized. Opioid binding sites have been demonstrated on lymphocytes, polymorphonuclear leukocytes, and platelets (4, 119) . ,-Endorphin and methionine-enkephalin have been shown to enhance the generation of CTLs (21) and NK cell cytotoxicity (42, 114) in vitro. However, the in vivo stress-induced release of opioid peptides has been found to enhance (82) or depress (142) NK activity, depending on the nature of the stressor. In addition, opioid peptides have been shown to enhance IL-2 production by lymphocytes (58) and IFN-y production by lymphocytes and NK cells (19, 113) . Opioid peptides have been reported to enhance (56, 57) or depress (56, 115, 116) mitogen-induced lymphocyte proliferation.
The above discussion has focused on the ability of neurotransmitters and hormones, released from the neuroendocrine system in response to stressors, to affect the function of cells of the immune system. Immune function is known to be an important mediator of infectious disease susceptibility and outcomes. The remainder of this review highlights studies examining the effects of stressors on the pathogenesis of, and immune responses to, infectious diseases.
STRESS AND MICROBIAL INFECTIONS
Perhaps the first observation that a stressful event could alter host-parasite relationships was reported by Ishigami (85) , who found that the incidence of tuberculosis correlated with a decrease in opsonic index of sera obtained from Japanese school children. The increase in tuberculosis in school children as well as in their instructors was attributed to the stressful environment found in the schools. Indeed, these observations may have been the foundation for the generally held belief that some stressful conditions serve as a cofactor in the development of active tuberculosis infections (30, 161) . However, despite this conventional wisdom, little or no experimental evidence is available that shows that stress affects the outcome of the relationship of a host with microbial pathogens (Table   1) .
Early studies that indicated that the HPA axis may be important in the modulation of infectious disease outcomes were limited to assessing the effects of exogenously injected adrenal cortical extract or cortisol. These studies showed that adrenal cortical preparations increased the susceptibility of experimental animals (primarily mice and rats) to pneumococcal infection (157) and to growth of Plasmodium berghei (86, 146) , Yersinia (Pasteurella) pestis (126) , Trichinella spiralis (28, 29) , and mycobacteria (136) . All of these studies concluded that treatment of animals with adrenal cortical preparations increased their susceptibility to microbial growth.
Several different stress paradigms have also been shown to adversely affect the survival of infected animals. Thus, Friedman et al. (50) showed that crowding stress altered the resistance of mice to malaria infection. In another study, crowding stress was shown to result in a marked increase in the susceptibility of mice to Salmonella typhimurium (39) . Hamil (49, 67) . The gene that controls resistance to mycobacterial growth in mice, termed Bcg, maps to a gene on chromosome 1 (130) . A group of genes that are linked to Bcg in mice form a syntenic group of genes on human chromosome 2q (141) . Studies by Johnson and Zwilling (91) , as well as by Denis et al. (35, 36) , have indicated that the differences in the growth patterns of the mycobacteria are due to differences in macrophage activation. Thus, mature tissue macrophages from BCG-resistant (Bcg) mice can control the growth of the mycobacteria, whereas macrophages from BCG-susceptible (Bcgv) mice cannot.
Given the differences in the ability of macrophages from congenic BCG-resistant and -susceptible mice to control mycobacterial growth, and the possibility that stress may alter the interaction between the host and the parasite, we have extended our studies to include an assessment of the role of HPA axis activation and mycobacterial growth. 4 h to allow for dissemination of the microorganisms, the mice were stressed by restraint for 1, 5, or 10 cycles (18 h per cycle). The number of CFU of mycobacteria was determined 12 days after injection in the spleens (A) and lungs (B) by plate count, using Middlebrook 7H11 agar. The number of CFU was adjusted to reflect differences in organ weight and body weight. The numbers of CFU isolated from the spleens and lungs prior to restraint were 13,519 CFU/g of spleen per g of body weight and 584 CFU/g of lung per g of body weight. The data are the means ± standard deviations for seven animals per group. The differences between 5-and 10-cycle restraint and control mice were significant by analysis of variance (P < 0.001). Reprinted from reference 18 with permission of the publisher.
suppressed MHC class II expression by macrophages from Bcg' mice but did not affect the expression of MHC class II expression by macrophages from Bcgf mice (164, 165) . We found that the timing of the stressor was an important factor in suppressing macrophage function and that the effect of stress was ameliorated by the intensity of the immunological stimulus (164) . In order to assess the effect of stress on mycobacterial growth, studies by Brown et al. (18) have used a restraint stress paradigm. Thus, mice were stressed by restraint immediately following the intravenous injection of 5 x 104 CFU of M. avium. Mice were stressed by restraint for 1, 5, or 10 cycles (18 h per cycle). Each cycle was followed by a 6-h rest period. The animals were sacrificed 12 days after the injection of mycobacteria, and the numbers of mycobacteria present in the spleens and lungs were determined by serial dilution and plate count, using Middlebrook 7H9 agar. The results in Fig. 1 (18) . The differences in the effect of multiple cycles of restraint were also apparent when we tested the ability of splenic macrophages to support the growth of mycobacteria (Fig. 2) . Thus, the macrophages from Bcg' mice restrained for multiple cycles were more permissive for mycobacterial growth than macrophages from nonrestrained control mice (macrophages from Bcgf mice did not show the same effect of restraint).
When we compared the effect of stress on the growth of mycobacteria in congenic BCG-resistant or -susceptible mice, we found that stress did not alter the growth of the mycobacteria in the resistant mice but increased the susceptibility of the susceptible mice (Fig. 3) .
The (62, 145, 156) . These studies suggest a linkage between stress and HSV recurrent disease. However, because of the retrospective nature of these studies and the failure of recent prospective studies to demonstrate significant relationships between stress and the onset of recurrent genital herpes episodes (93, 132) , it is difficult to argue for causality. Furthermore, the lack of immunologic and virologic assessment in these studies, with the exception of the study by Kemeny et (75, 98) . Recent studies have explored this possibility (63, 81, 95, 127, 149) , but only the study by Goodkin et al. (63) has found an association between stress and immune measures in HIV-1 infection. In this retrospective study of 11 asymptomatic seropositive homosexual males, high levels of stress and a low ability to cope with stress were associated with lower total lymphocyte counts. High ability to cope with stress was associated with greater numbers of CD4+ T lymphocytes in the peripheral blood. These results should be interpreted in light of the small sample size used in the study.
The effect of stress on the response to vaccination has also been examined. Two studies have investigated the relationships between stress and the antibody response to a recombinant hepatitis B vaccine. Petry et al. (128) studied the effects of stress on the peak antibody response to recombinant hepatitis B vaccination in 81 medical students. Higher levels of stress and anxiety during the 6-month period following the first dose of hepatitis B vaccine were associated with higher peak anti- Experimental animal models have also been used to study vaccine doses. These "early" seroconvertors were significantly the effects of stress on viral infection (Tables 3 and 4) . As with less anxious and less stressed than "late" seroconvertors.
microbial infections, some of these studies have assessed the However, the antibody titers to hepatitis B surface antigen effects of stressors on the resistance of farm animals to viral achieved by the third dose did not differ between early and late infection (3, 48, 121, 144, 153) . Shimuzu et al. (144) found that (125) found that mice subjected to immobilization stress developed encephalitis following an experimental Langat virus infection while nonstressed mice remained asymptomatic. Ben-Nathan et al. found that both cold and isolation stress induced the neuroinvasiveness of Sindbis virus (8) as well as of an attenuated, noninvasive strain of West Nile virus (9) .
The effects of various stressors on the immune responses to experimental viral infections have also been assessed. An early study showed that, in addition to increasing the susceptibility of mice to vesicular stomatitis virus infection, noise stress suppressed interferon production but did not alter the neutralizing antibody response to vesicular stomatitis virus (22) . More recently, in other murine models, forced exercise significantly reduced the titer of neutralizing antibody to coxsackievirus B3 (134) and increased the number of Tc<t,otoxiJTsuppressor cells in myocardial lesions (79) . In addition, immobilization suppressed IFN-ao production in response to influenza A virus infection (24) . In chickens, exposure to heat stress significantly lowered the antibody response to Newcastle disease virus (6) . replication, the induction and expression of the infected host's immune response, and the pathophysiology of the infectious disease process. Similarly, rodents have been used extensively in the characterization of neuroendocrine responses to stressors. The thrust of our research over the past 5 years has involved the use of well-characterized animal models of HSV and influenza virus infections to explore the nature of neuroendocrine-immune interactions in the setting of an experimental stressor. We have chosen to use repetitive cycles of restraint as a stressor and measurements of plasma corticosterone and tissue catecholamines as indicators of activation of the HPA axis and the SNS, respectively. In this setting, we have been able to examine cellular and humoral immune responses to viral infection and explore the effects of a stressor on the pathophysiology of an infectious disease process.
In our early studies, parametric variations of the stressor (restraint) were tested for effects on the cellular immune response and the pathophysiology of an influenza virus infection. We determined that although short cycles of restraint (<6 h) elevated plasma GC levels, they had no effect on the IL-2 response to influenza virus, nor did they alter the pathophysiology of the infectious process (46) . Similarly, a low number (<4 cycles) of longer cycles of restraint (>12 h) did not affect these parameters. However, when the number of restraint cycles was .4 (16 h per cycle), the IL-2 response was significantly depressed (Fig. 4) and mononuclear cell infiltration into the lung was diminished (143) . Once we had established that repetitive cycles of physical restraint could depress a T-cell response during infection, we used both models of acute viral infection (influenza virus and HSV) to explore stress-induced modulation of antiviral immunity and the effects of stress on viral pathogenesis.
To examine the effects of physical restraint on a viral infection in the respiratory tract, C57BL/6 male mice were infected intranasally with 32 hemagglutinating units of influenza A/PR8 virus, and restraint (16 h per cycle) was started 2 days prior to infection and continued throughout the infection period. Mice deprived of food and water, but not restrained, served as a control group, and a nontreated home cage group was also included. Physical restraint significantly altered the inflammatory response during infection; a pattern of reduced mononuclear cellular infiltration and less lung consolidation coincided with elevated plasma corticosterone levels. Virusspecific T-cell cytokine responses (IL-2) by lymph node and splenic lymphocytes were also significantly depressed in restraint-stressed animals (143) . The depressed IL-2 response to influenza virus was not due to a diminished frequency of virus-specific, cytokine-secreting T cells because limiting-dilution analysis indicated similar frequencies in restrained and control mice. However, the reduced cell density in the draining lymph nodes of restrained mice probably was responsible for the diminished IL-2 response as the absolute number of virus-specific T cells in the node was significantly different from that in the control (46) .
Whereas physical restraint had a profound effect on virusspecific cytokine responses, the titers of antiinfluenza antibody 10 days postinfection were similar in restrained and control animals (143) . However, when the kinetics and isotype switching were studied during influenza virus infection, it was determined that physical restraint altered the kinetics of the antibody response. Seroconversion in the immunoglobulin M (IgM) isotype was delayed by restraint, and isotype switching from IgM to IgG and from IgG to IgA was significantly delayed (Fig. 5) . Ultimately, however, restraint did not alter the magnitude or class of the humoral response (47) .
As mentioned previously, restraint stress reduced the level of mononuclear infiltration in the lungs and, in addition, the cell densities of the draining lymph nodes (superficial cervical and mediastinal lymph nodes) were markedly reduced (46, 76) . Reduced inflammation in the lung was not due to an effect of restraint stress on virus replication in the lungs as the kinetics and titers of influenza virus in restrained and control mice were not significantly different (46) .
Restraint and restraint plus infection markedly elevated plasma corticosterone levels (143) . To determine the role of corticosterone in suppression of the lymphadenopathy response, mice were adrenalectomized 2 weeks prior to restraint and infection. Mice receiving sham surgeries served as a control. Adrenalectomy restored the cellularity of the mediastinal lymph node in restraint-stressed mice, thus suggesting that reduced cellularity in the node was adrenal-corticosterone dependent (46) . To responses. Cytotoxic responses of NK cells and CD8+ T cells were also suppressed by restraint (12) . This probably accounted for the higher titers of HSV-1 in the footpads of the restrained mice. Restraint had a differential effect on the T-cell subsets (CD4+ and CD8+ T cells). Restraint diminished the IL-2 response in the draining lymph node, but the frequencies of virus-specific IL-2-secreting T cells were similar in control and restrained groups, as observed in the influenza virus model. Restraint also diminished the cytolytic activity of class I-restricted CTL recovered from the nodes; however, the frequency of CTL precursors in the node was reduced. The effects of restraint on the development of HSV-specific memory CTL (CTLm) responses was examined, as was the effect of stress on HSV-specific CTLm localization and proliferation in the popliteal lymph node following reexposure to HSV. Restraint stress did not inhibit the generation of CTLm; however, it did inhibit the ability to activate CTLm to the lytic phenotype. Furthermore, in mice primed to HSV prior to restraint, the application of the stressor prevented in vivo activation and/or migration of HSV-specific CTLm in the popliteal lymph nodes. These findings suggest that virus-specific immunological memory can be inhibited by physiological changes associated with experimental stressors. Further, it is possible that such immune inhibition may provide a mechanism that accounts for the development of recrudescent herpetic disease (13) .
Adrenalectomy restored the generation of HSV-specific CTL in the lymph nodes of restrained mice. However, administration of exogenous corticosterone alone to adrenalectomized mice did not suppress CTL generation (14) . An adrenalindependent mechanism induced by restraint synergized with corticosterone to suppress CTL development. This study suggests that both adrenal-dependent and -independent mechanisms contribute to stress-induced modulation of HSV immunity. Similar observations of depressed cell-mediated immune responses and increased pathogenicity were made in the murine HSV-1 model when mild electric shock was used as the stressor (104) .
In recent studies designed to elucidate the mechanisms of stress-induced immunomodulation, treatment of restrained, HSV-infected animals with a GC receptor antagonist (RU486) restored the cellularity of the draining popliteal lymph nodes, but cytolytic T-cell activation in the lymph node remained depressed. On the other hand, treatment of these mice with nadolol (a beta-adrenergic receptor antagonist) partially restored cytolytic T-cell activity but failed to increase the cellularity of the popliteal node. However, treatment of restrained mice with a combination of the two drugs completely restored HSV-specific CTL activity to the popliteal lymph node (37) . CONCLUSIONS Overall, the human and animal research reviewed in this article demonstrates the important health consequences of stress. These data provide evidence for an association between stress and the pathogenesis of infectious disease and suggest that the effects of stress on infectious disease are mediated through the neuroendocrine-immune interactions. Though there is abundant in vitro research demonstrating that products of the HPA axis and the SNS can modulate in vitro correlates of immune function, there is limited in vivo research exploring such modulation in the context of infectious disease. Further studies exploring the effects of neuroendocrine-immune interactions on microbial pathogenesis and immunity during an infectious disease are needed to dissect the mechanisms by which stress modulates these processes.
